The short version
12 companies supply this market — deep enough that no single failure threatens the supply. The price is down 14% over the past year, to $0.0812 per unit. A Class II recall hit this product in the past year (Glenmark Pharmaceuticals Inc., USA). One of its named manufacturing plants, Glenmark Pharmaceuticals Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.